RecruitingNCT02363595
Genomic Predictors of Papillary Microcarcinoma Disease Progression
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
750 participants
Start Date
Dec 31, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
The study is being done to answer the following question: What are the specific clinical and molecular features that will help us predict which small thyroid cancers are likely to grow and be problematic? Therefore, the purpose of this study is to identify specific clinical and molecular characteristics that are predictive of tumor progression in small thyroid cancers.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Biopsy proven papillary thyroid cancer (or suspicious for papillary thyroid cancer) confirmed by MSKCC cytopathologist.
- Being followed with active surveillance at MSKCC
- Biopsied index nodule less than or equal to 2 cm in maximum dimension
- Thyroid and neck US performed and interpreted by a MSKCC radiologist within 6 months prior to study entry.
Exclusion Criteria2
- Biopsied index nodule greater than 2 cm in any dimension
- Age less than 18 yrs old
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02363595